Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Novel Surgical Technique Enables Scarless Removal of Large Polyps

By HospiMedica International staff writers
Posted on 05 Sep 2011
A new operating platform for Trans-Anal Minimally Invasive Surgery (TAMIS) allows surgeons to excise large rectal polyps and tumor masses that cannot be completely removed during a routine colonoscopy.

During a TAMIS procedure, thin surgical instruments are placed through a soft but stable surgical platform--similar to a single incision laparoscopy (SIL) port--that rests inside the anus. More...
The platform permits full visualization of the rectal growth, allowing surgeons to precisely access and excise the abnormality. The intact growth can then be removed through the anus, allowing pathologists to more accurately evaluate and diagnose its thickness. The tissue defect where the growth was removed is then closed with internal stitches; there are no permanent scars on the abdomen or around the anus.

TAMIS, which was pioneered at Florida Hospital (Winter Park, USA) by Sam Atallah, MD, will likely serve as the future platform for rectal natural orifice translumenal endoscopic surgery (NOTES), and may also have implications for treating patients with familial adenomatous polyposis, Gardner's syndrome, and Lynch syndrome, inherited genetic conditions that result in the mass growth of polyps.

“With the use of this new surgical platform, we can now offer patients an innovative, less invasive procedure to remove advanced polyps with significantly less pain and scarring compared to the standard surgical procedure,” said Elisabeth McLemore, MD, a colorectal surgeon at the University of California, San Diego (UCSD; USA), and the third surgeon in the world to perform the procedure. “Instead of a major abdominal operation with removal and reconstruction of the colon and rectum, we can remove the growth by operating through an existing natural body opening.”

“What we are seeing here is an evolution of natural orifice translumenal endoscopic surgery, the ability to perform complex operations through natural body openings,” added Professor Mark Talamini, MD, chairman of surgery and codirector of the Center for the Future of Surgery at the UCSD Health System. “Four years ago we predicted that NOTES would evolve to treat early forms of cancers, and that is what we are seeing now at UC San Diego.”

Related Links:
Florida Hospital
University of California, San Diego


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gold Member
Blood Gas Analyzer
i-Check200
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.